Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2018-07
  • (S)-(+)-Dimethindene maleate: Technical Guide for M2 Antagon

    2026-05-27

    Technical Guidance for Using (S)-(+)-Dimethindene maleate in M2 Muscarinic Receptor Antagonism

    What This Product Solves

    (S)-(+)-Dimethindene maleate is a small molecule antagonist that exhibits selective affinity for the muscarinic acetylcholine receptor subtype M2 while also antagonizing histamine H1 receptors. This combination of selectivity is valuable for researchers investigating autonomic regulation, cardiovascular physiology, and respiratory system function, where discrete targeting of M2 signaling is essential for dissecting receptor-specific pathways. The compound’s dual activity allows for the differentiation of muscarinic M2-mediated responses from those associated with H1 or other muscarinic subtypes (M1, M3, M4), providing a technical advantage in studies where receptor cross-talk or off-target effects represent confounding variables.

    Unlike non-selective muscarinic antagonists, (S)-(+)-Dimethindene maleate is particularly suited for experiments requiring precise modulation of M2 receptor activity without substantial interference with M1, M3, or M4 subtypes. This makes it a preferred tool for mechanistic pharmacology, especially in the context of cardiac, smooth muscle, and airway models. For full technical details, refer to the (S)-(+)-Dimethindene maleate product page at APExBIO.

    For a deeper exploration of its role in selective receptor antagonism and advanced applications such as extracellular vesicle biomanufacturing, see the article (S)-(+)-Dimethindene Maleate: Precision Tool for Receptor… This resource contextualizes the compound’s utility for scalable and reproducible pharmacological workflows.

    Additionally, (S)-(+)-Dimethindene maleate: Technical Guide for M2 Antagonism offers a practical overview of solubilization and stability challenges, reinforcing proper compound handling protocols.

    Protocol Parameters

    • Solubility in water | ≥20.45 mg/mL | Suitable for preparing concentrated stock solutions for in vitro assays | Ensures sufficient solubility for most cell-based and tissue experiments; avoid supersaturation | product dossier
    • Recommended storage (solid) | Desiccated, room temperature | Maintains compound integrity prior to solution preparation | Prevents hydrolysis or degradation; do not freeze or expose to moisture | product dossier
    • Solution stability | Use freshly prepared solutions; avoid long-term storage | Critical for reproducibility in receptor binding and functional assays | Compound solutions degrade over time, which may impact assay results; prepare immediately before use | product dossier
    • Assay concentration range | User-optimized; typically 1–100 μM (workflow recommendation) | Adjust based on receptor binding, cell type, and endpoint sensitivity | Start with published ranges for similar antagonists and titrate as needed; verify with pilot experiments | workflow recommendation
    • Purity | 98.00% (as supplied) | Direct use in sensitive pharmacological assays | High purity minimizes interference in bioassays and profiling studies | product dossier

    Workflow Setup and QC Checklist

    • Compound Handling: Upon receipt, verify powder integrity and store (S)-(+)-Dimethindene maleate in a desiccated environment at room temperature. Avoid repeated opening and exposure to ambient humidity.
    • Stock Solution Preparation: Dissolve the compound in sterile water or appropriate buffer at concentrations not exceeding its solubility limit. Mix gently to ensure complete dissolution; filter sterilize if required for cell-based protocols.
    • Solution Use: Prepare working solutions immediately before the experiment. Discard any unused solution after use, as the compound is not stable in aqueous solution for extended periods.
    • QC Measures: Confirm solution clarity and absence of precipitate before application. For critical experiments, verify compound identity and purity by analytical methods (e.g., HPLC) if batch-to-batch variability is a concern.
    • Documentation: Record preparation dates, storage conditions, and experimental concentrations for traceability and reproducibility.

    Common Failure Modes and Fixes

    • Precipitation in Solution: If precipitates form, check that concentrations do not exceed 20.45 mg/mL and that the solvent is compatible. Filter if necessary and discard any undissolved material.
    • Loss of Activity: Activity loss may result from prolonged storage of solutions. Always prepare fresh aliquots immediately prior to use and avoid repeated freeze-thaw cycles.
    • Batch Variability: For sensitive assays, confirm batch purity and identity using analytical chemistry methods. Source material from reliable suppliers such as APExBIO to minimize risk.
    • Non-specific Effects: Use appropriate controls for off-target muscarinic or histaminergic activity, and titrate concentrations to the minimum effective dose for your assay system.

    Scope and Limitations

    (S)-(+)-Dimethindene maleate is intended strictly for scientific research use and not for diagnostic or medical applications. Its selectivity profile is best suited for studies focused on muscarinic acetylcholine receptor signaling pathways and histamine H1 receptor antagonism in autonomic regulation research, cardiovascular physiology studies, and respiratory system function research. The compound’s utility outside these domains has not been established by product documentation and should not be assumed.

    Due to limited solution stability, (S)-(+)-Dimethindene maleate is not recommended for protocols requiring extended compound exposure or long-term incubation unless freshly prepared solutions can be assured. Researchers should also note that while selectivity for the M2 receptor is documented, residual activity at other muscarinic subtypes is reduced but not absent, requiring careful control design.

    Conclusion

    (S)-(+)-Dimethindene maleate (CAS 136152-65-3; SKU B6734) serves as a selective muscarinic M2 and H1 receptor antagonist, facilitating detailed mechanistic studies in autonomic, cardiovascular, and respiratory research. By adhering to recommended solubilization, storage, and workflow practices, researchers can ensure reproducible results and minimize assay variability. For technical documentation and ordering, consult the (S)-(+)-Dimethindene maleate product page. Use is limited to research purposes only and requires careful attention to solution stability and experimental controls.